Literature DB >> 16819580

The management of conditioned nutritional requirements in heart failure.

Marc L Allard1, Khursheed N Jeejeebhoy, Michael J Sole.   

Abstract

Patients suffering from congestive heart failure exhibit impaired myocardial energy production, myocyte calcium overload and increased oxidative stress. Nutritional factors known to be important for myocardial energy production, calcium homeostasis and the reduction of oxidative stress, such as thiamine, riboflavin, pyridoxine, L-carnitine, coenzyme Q10, creatine and taurine are reduced in this patient population. Furthermore, deficiencies of taurine, carnitine, and thiamine are established primary causes of dilated cardiomyopathy. Studies in animals and limited trials in humans have shown that dietary replacement of some of these compounds in heart failure can significantly restore depleted levels and may result in improvement in myocardial structure and function as well as exercise capacity. Larger scale studies examining micronutrient depletion in heart failure patients, and the benefits of dietary replacement need to be performed. At the present time, it is our belief that these conditioned nutritional requirements, if unsatisfied, contribute to myocyte dysfunction and loss; thus, restoration of nutritional deficiencies should be part of the overall therapeutic strategy for patients with congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819580     DOI: 10.1007/s10741-006-9195-3

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  72 in total

1.  Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration.

Authors:  I Rizos
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

2.  Increased oxidative stress in patients with congestive heart failure.

Authors:  M Keith; A Geranmayegan; M J Sole; R Kurian; A Robinson; A S Omran; K N Jeejeebhoy
Journal:  J Am Coll Cardiol       Date:  1998-05       Impact factor: 24.094

3.  Lovastatin decreases coenzyme Q levels in humans.

Authors:  K Folkers; P Langsjoen; R Willis; P Richardson; L J Xia; C Q Ye; H Tamagawa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans.

Authors:  A Casey; D Constantin-Teodosiu; S Howell; E Hultman; P L Greenhaff
Journal:  Am J Physiol       Date:  1996-07

5.  Vitamin E and oxidative stress in the heart of the cardiomyopathic syrian hamster.

Authors:  R K Li; M J Sole; D A Mickle; J Schimmer; D Goldstein
Journal:  Free Radic Biol Med       Date:  1998-01-15       Impact factor: 7.376

6.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

Authors:  S Neubauer; M Horn; M Cramer; K Harre; J B Newell; W Peters; T Pabst; G Ertl; D Hahn; J S Ingwall; K Kochsiek
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

7.  Beneficial effect of taurine in rabbits with chronic congestive heart failure.

Authors:  K Takihara; J Azuma; N Awata; H Ohta; T Hamaguchi; A Sawamura; Y Tanaka; S Kishimoto; N Sperelakis
Journal:  Am Heart J       Date:  1986-12       Impact factor: 4.749

8.  Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure--effects of long-term dietary supplementation.

Authors:  M Broqvist; H Arnqvist; U Dahlström; J Larsson; E Nylander; J Permert
Journal:  Eur Heart J       Date:  1994-12       Impact factor: 29.983

9.  Cysteine and glycine supplementation modulate the metabolic response to tumor necrosis factor alpha in rats fed a low protein diet.

Authors:  R F Grimble; A A Jackson; C Persaud; M J Wride; F Delers; R Engler
Journal:  J Nutr       Date:  1992-11       Impact factor: 4.798

10.  Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study.

Authors:  H Seligmann; H Halkin; S Rauchfleisch; N Kaufmann; M Motro; Z Vered; D Ezra
Journal:  Am J Med       Date:  1991-08       Impact factor: 4.965

View more
  14 in total

Review 1.  The clinical significance and costs of herbs and food supplements used by complementary and alternative medicine for the treatment of cardiovascular diseases and hypertension.

Authors:  S G Chrysant
Journal:  J Hum Hypertens       Date:  2015-05-21       Impact factor: 3.012

Review 2.  Amino acids and derivatives, a new treatment of chronic heart failure?

Authors:  Valentina Carubelli; Anna Isotta Castrini; Valentina Lazzarini; Mihai Gheorghiade; Marco Metra; Carlo Lombardi
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

3.  Nutritional screening based on the controlling nutritional status (CONUT) score at the time of admission is useful for long-term prognostic prediction in patients with heart failure requiring hospitalization.

Authors:  Isao Nishi; Yoshihiro Seo; Yoshie Hamada-Harimura; Kimi Sato; Seika Sai; Masayoshi Yamamoto; Tomoko Ishizu; Akinori Sugano; Kenichi Obara; Longmei Wu; Shoji Suzuki; Akira Koike; Kazutaka Aonuma
Journal:  Heart Vessels       Date:  2017-06-01       Impact factor: 2.037

4.  Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat.

Authors:  Shane A Perrine; Mark S Michaels; Farhad Ghoddoussi; Elisabeth M Hyde; Manuel E Tancer; Matthew P Galloway
Journal:  NMR Biomed       Date:  2009-05       Impact factor: 4.044

5.  The potential health benefits of taurine in cardiovascular disease.

Authors:  Yan-Jun Xu; Amarjit S Arneja; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2008

6.  Differential HMG-CoA lyase expression in human tissues provides clues about 3-hydroxy-3-methylglutaric aciduria.

Authors:  Beatriz Puisac; María Arnedo; Cesar H Casale; María Pilar Ribate; Tomás Castiella; Feliciano J Ramos; Antonia Ribes; Celia Pérez-Cerdá; Nuria Casals; Fausto G Hegardt; Juan Pié
Journal:  J Inherit Metab Dis       Date:  2010-06-08       Impact factor: 4.982

7.  Effects of nutraceutical diet integration, with coenzyme Q10 (Q-Ter multicomposite) and creatine, on dyspnea, exercise tolerance, and quality of life in COPD patients with chronic respiratory failure.

Authors:  Stefano Marinari; Maria Rosaria Manigrasso; Fernando De Benedetto
Journal:  Multidiscip Respir Med       Date:  2013-06-21

8.  A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency.

Authors:  Alexander A C Leung; Alicia K Chan; Justin A Ezekowitz; Alexander K C Leung
Journal:  Case Rep Med       Date:  2009-11-04

9.  Atrophic cardiac remodeling induced by taurine deficiency in Wistar rats.

Authors:  Mariele Castilho Pansani; Paula S Azevedo; Bruna Paola Murino Rafacho; Marcos F Minicucci; Fernanda Chiuso-Minicucci; Sofia Gonçalves Zorzella-Pezavento; Julio Sergio Marchini; Gilberto João Padovan; Ana Angelica Henrique Fernandes; Beatriz B Matsubara; Luiz S Matsubara; Leonardo A M Zornoff; Sergio A R Paiva
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Effects of Complementary Creatine Monohydrate and Physical Training on Inflammatory and Endothelial Dysfunction Markers Among Heart Failure Patients.

Authors:  Farajollah Hemati; Asghar Rahmani; Khairollah Asadollahi; Koroush Soleimannejad; Zahra Khalighi
Journal:  Asian J Sports Med       Date:  2016-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.